Abacavir and warfarin modulate allosterically kinetics of NO dissociation from ferrous nitrosylated human serum heme-albumin

Biochemical and Biophysical Research Communications

Volumn 369, Issue 2, 2008, Pages 686-691

  Ascenzi, Paolo ^a,b   Imperi, Francesco ^a,b   Coletta, Massimo ^c   Fasano, Mauro ^d  

^a ROMA TRE UNIVERSITY   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

Abacavir; Allostery; Drug dependent denitrosylation kinetics; Ferrous nitrosylated human serum heme albumin; Warfarin

Indexed keywords

ABACAVIR; FERROUS ION; HEME; HUMAN SERUM ALBUMIN; NITRIC OXIDE; WARFARIN;

ALLOSTERISM; ARTICLE; CHEMICAL REACTION KINETICS; CONCENTRATION RESPONSE; DISSOCIATION; DRUG PROTEIN BINDING; HUMAN; NITROSYLATION; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN STABILITY;

ANTICOAGULANTS; DIDEOXYNUCLEOSIDES; HUMANS; IRON; KINETICS; NITRIC OXIDE; SERUM ALBUMIN; WARFARIN;

EID: 40849114506     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.02.077     Document Type: Article

References (54)

1. Sudlow G., Birkett D.J., and Wade D.N. The characterization of two specific drug binding sites on human serum albumin. Mol. Pharmacol. 11 (1975) 824-832
2. Carter D.C., and Ho J.X. Structure of serum albumin. Adv. Protein Chem. 45 (1994) 153-203
3. In: Peters Jr. T. (Ed). All about Albumin: Biochemistry, Genetics and Medical Applications (1996), Academic Press, San Diego and London
4. Bertucci C., and Domenici E. Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr. Med. Chem. 9 (2002) 1463-1481
5. Curry S. Beyond expansion: structural studies on the transport roles of human serum albumin. Vox Sang. 83 1 (2002) 315-319
6. Kragh-Hansen U., Chuang V.T., and Otagiri M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol. Pharm. Bull. 25 (2002) 695-704
7. Sakurai Y., Ma S.F., Watanabe H., Yamaotsu N., Hirono S., Kurono Y., Kragh-Hansen U., and Otagiri M. Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substrates. Pharm. Res. 21 (2004) 285-292
8. Sułkowska A., Bojko B., Równicka J., and Sułkowski W. Competition of drugs to serum albumin in combination therapy. Biopolymers 74 (2004) 256-262
9. Ascenzi P., Bocedi A., Notari S., Menegatti E., and Fasano M. Heme impairs allosterically drug binding to human serum albumin Sudlow's site I. Biochem. Biophys. Res. Commun. 334 (2005) 481-486
10. Bocedi A., Notari S., Menegatti E., Fanali G., Fasano M., and Ascenzi P. Allosteric modulation of anti-HIV drug and ferric heme binding to human serum albumin. FEBS J. 272 (2005) 6287-6296
11. Fasano M., Curry S., Terreno E., Galliano M., Fanali G., Narciso P., Notari S., and Ascenzi P. The extraordinary ligand binding properties of human serum albumin. IUBMB Life 57 (2005) 787-796
12. Ghuman J., Zunszain P.A., Petitpas I., Bhattacharya A.A., Otagiri M., and Curry S. Structural basis of the drug-binding specificity of human serum albumin. J. Mol. Biol. 353 (2005) 38-52
13. Ascenzi P., Bocedi A., Notari S., Fanali G., Fesce R., and Fasano M. Allosteric modulation of drug binding to human serum albumin. Mini Rev. Med. Chem. 6 (2006) 483-489
14. Ascoli G.A., Domenici E., and Bertucci C. Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism. Chirality 18 (2006) 667-679
15. Chuang V.T., and Otagiri M. Stereoselective binding of human serum albumin. Chirality 18 (2006) 159-166
16. He X., and Carter D.C. Atomic structure and chemistry of human serum albumin. Nature 358 (1992) 209-215
17. Sugio S., Kashima A., Mochizuki S., Noda M., and Kobayashi K. Crystal structure of human serum albumin at 2.5 Å resolution. Protein Eng. 12 (1999) 439-446
18. Wardell M., Wang Z., Ho J.X., Robert J., Ruker F., Ruble J., and Carter D.C. The atomic structure of human methemalbumin at 1.9 Å. Biochem. Biophys. Res. Commun. 291 (2002) 813-819
19. Zunszain P.A., Ghuman J., Komatsu T., Tsuchida E., and Curry S. Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Struct. Biol. 3 (2003) 6
20. Baroni S., Mattu M., Vannini A., Cipollone R., Aime S., Ascenzi P., and Fasano M. Effect of ibuprofen and warfarin on the allosteric properties of haem-human serum albumin: a spectroscopic study. Eur. J. Biochem. 268 (2001) 6214-6220
21. Janssen L.H., Van Wilgenburg M.T., and Wilting J. Human serum albumin as an allosteric two-state protein: evidence from effects of calcium and warfarin on proton binding behaviour. Biochim. Biophys. Acta 669 (1981) 244-250
22. Fanali G., Fesce R., Agrati C., Ascenzi P., and Fasano M. Allosteric modulation of myristate and Mn(III)heme binding to human serum albumin: optical and NMR spectroscopy characterization. FEBS J. 272 (2005) 4672-4683
23. Fanali G., Bocedi A., Ascenzi P., and Fasano M. Modulation of heme and myristate binding to human serum albumin by anti-HIV drugs. An optical and NMR spectroscopic study. FEBS J. 274 (2007) 4491-4502
24. Marden M.C., Hazard E.S., Leclerc L., and Gibson Q.H. Flash photolysis of the serum albumin-heme-CO complex. Biochemistry 28 (1989) 4422-4426
25. Kharitonov V.G., Sharma V.S., Magde D., and Koesling D. Kinetics of nitric oxide dissociation from five- and six-coordinate nitrosyl hemes and heme proteins, including soluble guanylate cyclase. Biochemistry 36 (1997) 6814-6818
26. 2 binding to human serum albumin-heme hybrid. Bioconjug. Chem. 11 (2000) 772-776
27. Mattu M., Vannini A., Coletta M., Fasano M., and Ascenzi P. Effect of bezafibrate and clofibrate on the heme-iron geometry of ferrous nitrosylated heme-human serum albumin: an EPR study. J. Inorg. Biochem. 84 (2001) 293-296
28. Monzani E., Bonafé B., Fallarini A., Redaelli C., Casella L., Minchiotti L., and Galliano M. Enzymatic properties of hemalbumin. Biochim. Biophys. Acta 1547 (2001) 302-312
29. Fasano M., Mattu M., Coletta M., and Ascenzi P. The heme-iron geometry of ferrous nitrosylated heme-serum lipoproteins, hemopexin, and albumin: a comparative EPR study. J. Inorg. Biochem. 91 (2002) 487-490
30. Kamal J.K., and Behere D.V. Spectroscopic studies on human serum albumin and methemalbumin: optical, steady-state, and picosecond time-resolved fluorescence studies, and kinetics of substrate oxidation by methemalbumin. J. Biol. Inorg. Chem. 7 (2002) 273-283
31. 2 and CO binding properties of artificial hemoproteins formed by complexing iron protoporphyrin IX with human serum albumin mutants. J. Am. Chem. Soc. 127 (2005) 15933-15942
32. 2 binding of iron protoporphyrin IX by variation of distal amino acids. J. Am. Chem. Soc. 129 (2007) 11286-11295
33. Ascenzi P., and Fasano M. Abacavir modulates peroxynitrite-mediated oxidation of ferrous nitrosylated human serum heme-albumin. Biochem. Biophys. Res. Commun. 353 (2007) 469-474
34. Fanali G., Ascenzi P., and Fasano M. Effect of prototypic drugs ibuprofen and warfarin on global chaotropic unfolding of human serum heme-albumin: a fast-field-cycling 1H-NMR relaxometric study. Biophys. Chem. 129 (2007) 29-35
35. Bocedi A., Notari S., Narciso P., Bolli A., Fasano M., and Ascenzi P. Binding of anti-HIV drugs to human serum albumin. IUBMB Life 56 (2004) 609-614
36. Moore E.G., and Gibson Q.H. Cooperativity in the dissociation of nitric oxide from hemoglobin. J. Biol. Chem. 251 (1976) 2788-2794
37. Antonini E., and Brunori M. Hemoglobin and Myoglobin in their Reactions with Ligands (1971), North-Holland Publishing Co., Amsterdam
38. Harutyunyan E.H., Safonova T.N., Kuranova I.P., Popov A.N., Teplyakov A.V., Obmolova G.V., Vainshtein B.K., Dodson G.G., and Wilson J.C. The binding of carbon monoxide and nitric oxide to leghaemoglobin in comparison with other haemoglobins. J. Mol. Biol. 264 (1996) 152-161
39. Hargrove M.S., Barry J.K., Brucker E.A., Berry M.B., Phillips Jr. G.N., Olson J.S., Arredondo-Peter R., Dean J.M., Klucas R.V., and Sarath G. Characterization of recombinant soybean leghemoglobin a and apolar distal histidine mutants. J. Mol. Biol. 266 (1997) 1032-1042
40. Van Doorslaer S., Dewilde S., Kiger L., Nistor S.V., Goovaerts E., Marden M.C., and Moens L. Nitric oxide binding properties of neuroglobin. A characterization by EPR and flash photolysis. J. Biol. Chem. 278 (2003) 4919-4925
41. Herold S., and Röck G. Mechanistic studies of the oxygen-mediated oxidation of nitrosylhemoglobin. Biochemistry 44 (2005) 6223-6231
42. 2 -mediated oxidation of hemopexin-heme(II)-NO. Biochem. Biophys. Res. Commun. 345 (2006) 704-712
43. 2 -mediated oxidation of ferrous nitrosylated Mycobacterium leprae truncated hemoglobin O. Biochem. Biophys. Res. Commun. 357 (2007) 809-814
44. Duprat A.F., Traylor T.G., Wu G.-Z., Coletta M., Sharma V.S., Walda K.N., and Magde D. Myoglobin-NO at low pH: free four-coordinated heme in the protein pocket. Biochemistry 34 (1995) 2634-2644
45. Mukai M., Savard P.Y., Ouellet H., Guertin M., and Yeh S.R. Unique ligand-protein interactions in a new truncated hemoglobin from Mycobacterium tuberculosis. Biochemistry 41 (2002) 3897-3905
46. Milani M., Savard P.Y., Ouellet H., Ascenzi P., Guertin M., and Bolognesi M. A TyrCD1/TrpG8 hydrogen bond network and a TyrB10TyrCD1 covalent link shape the heme distal site of Mycobacterium tuberculosis hemoglobin O. Proc. Natl. Acad. Sci. USA 100 (2003) 5766-5771
47. Martin E., Berka V., Bogatenkova E., Murad F., and Tsai A.L. Ligand selectivity of soluble guanylyl cyclase: effect of the hydrogen-bonding tyrosine in the distal heme pocket on binding of oxygen, nitric oxide, and carbon monoxide. J. Biol. Chem. 281 (2006) 27836-27845
48. Chan N.L., Kavanaugh J.S., Rogers P.H., and Arnone A. Crystallographic analysis of the interaction of nitric oxide with quaternary-T human haemoglobin. Biochemistry 43 (2004) 118-132
49. Paoli M., Anderson B.F., Baker H.M., Morgan W.T., Smith A., and Baker E.N. Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two β-propeller domains. Nat. Struct. Biol. 6 (1999) 926-931
50. Copeland D.M., West A.H., and Richter-Addo G.B. Crystal structures of ferrous horse heart myoglobin complexed with nitric oxide and nitrosoethane. Proteins 53 (2003) 182-192
51. Pesce A., Dewilde S., Nardini M., Moens L., Ascenzi P., Hankeln T., Burmester T., and Bolognesi M. Human brain neuroglobin structure reveals a distinct mode of controlling oxygen affinity. Structure 11 (2003) 1087-1095
52. de Sanctis D., Pesce A., Nardini M., Bolognesi M., Bocedi A., and Ascenzi P. Structure-function relationships in the growing hexa-coordinate hemoglobin sub-family. IUBMB Life 56 (2004) 643-651 Erratum in: IUBMB Life 57 (2005) 459-460
53. Vallone B., Nienhaus K., Matthes A., Brunori M., and Nienhaus G.U. The structure of carbonmonoxy neuroglobin reveals a heme-sliding mechanism for-control of ligand affinity. Proc. Natl. Acad. Sci. USA 101 (2004) 17351-17356
54. Dockal M., Chang M., Carter D.C., and Rüker F. Five recombinant fragments of human serum albumin-tools for the characterization of the warfarin binding site. Protein Sci. 9 (2000) 1455-1465